Systematic Critical Review of Genetic Factors Associated with Cisplatin-induced Ototoxicity: Canadian Pharmacogenomics Network for Drug Safety 2022 Update.
Saved in:
| Title: | Systematic Critical Review of Genetic Factors Associated with Cisplatin-induced Ototoxicity: Canadian Pharmacogenomics Network for Drug Safety 2022 Update. |
|---|---|
| Authors: | Scott EN; BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.; Department of Medical Genetics, Faculty of Medicine, University of British Columbia (UBC), Vancouver, British Columbia, Canada., Joseph AA; BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.; Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, UBC, Vancouver, British Columbia, Canada., Dhanda A; BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.; Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, UBC, Vancouver, British Columbia, Canada., Tanoshima R; Department of Pediatrics, Yokohama City University Hospital, Yokohama, Japan.; YCU Center for Novel and Exploratory Clinical Trials, Yokohama City University Hospital, Yokohama, Japan., Brooks B; Audiology and Speech Pathology Department, British Columbia Children's Hospital, Vancouver, British Columbia, Canada.; School of Audiology and Speech Science, UBC, Vancouver, British Columbia, Canada., Rassekh SR; BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.; Division of Oncology, Hematology and Bone Marrow Transplant, British Columbia Children's Hospital and UBC, Vancouver, British Columbia, Canada., Ross CJD; BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.; Department of Medical Genetics, Faculty of Medicine, University of British Columbia (UBC), Vancouver, British Columbia, Canada.; Faculty of Pharmaceutical Sciences, UBC, Vancouver, British Columbia, Canada., Carleton BC; BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.; Department of Medical Genetics, Faculty of Medicine, University of British Columbia (UBC), Vancouver, British Columbia, Canada.; Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, UBC, Vancouver, British Columbia, Canada.; Pharmaceutical Outcomes Programme, British Columbia Children's Hospital, Vancouver, British Columbia, Canada; and., Loucks CM; BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.; Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, UBC, Vancouver, British Columbia, Canada.; Department of Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine, UBC, Vancouver, British Columbia, Canada. |
| Source: | Therapeutic drug monitoring [Ther Drug Monit] 2023 Dec 01; Vol. 45 (6), pp. 714-730. Date of Electronic Publication: 2023 Jul 13. |
| Publication Type: | Systematic Review; Journal Article |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7909660 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-3694 (Electronic) Linking ISSN: 01634356 NLM ISO Abbreviation: Ther Drug Monit Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
